OTA 2007 Posters - Pediatrics
Scientific Poster #173 Pediatrics OTA-2007
Same-Level Concomitant Fractures of the Tibia and Fibula: Effect of Location in the Leg
Rakesh P. Mashru, MD1 (n); Glenn E. Lipton, MD1 (n); James T. Guille, MD1 (n); J. Richard Bowen, MD2 (n);
1Brandywine Institute of Orthopaedics, Pottstown, Pennsylvania, USA;
2Alfred I. duPont Hospital for Children, Wilmington, Delaware, USA
Scientific Poster #174 Pediatrics OTA-2007
Reduction of Supracondylar Elbow Fractures in Children Using an Intercalary Pin
Steven A. Lovejoy, MD (n);
Vanderbilt Children’s Hospital, Nashville, Tennessee, USA
Scientific Poster #175 Pediatrics OTA-2007
Bioabsorbable versus Metallic Screw Fixation for Epiphyseal Fractures of the
Distal Tibia
David A. Podeszwa, MD (n); Philip Wilson, MD (n); Amy Holland, CPNP (n);
Lawson Copley, MD (n);
University of Texas Southwestern Medical Center, Dallas, Texas, USA
Alison Rozansky, MD1 (n); Dennis Weiner, MD2 (n); Mark Adamczyk, MD2 (n);
William Schrader, MD2 (n); Patrick Riley, MD2 (n); Kerwyn Jones, MD2 (n);
1Akron General Medical Center, Akron, Ohio, USA
2Children’s Hospital Medical Center of Akron, Akron, Ohio, USA
Scientific Poster #177 Pediatrics OTA-2007
Child Abuse in America: Who, What, When, and Where
Daniel P. Bullock, MD (n); Kenneth J. Koval, MD (n); Kathleen Y. Moen, MD (n);
Brian T. Carney, MD (n); Kevin F. Spratt, PhD (n);
Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA
Scientific Poster #178 Pediatrics OTA-2007
Fractures of the Distal Humeral Metaphyseal-Diaphyseal Junction in Children
Reginald Fayssoux, MD1 (n); Lawrence Stankovits, MD2 (n);
James T. Guille, MD3 (n); Marcin E. Domzalski, MD4 (n);
1Drexel University College of Medicine, Philadelphia, Pennsylvania, USA;
2Pediatric Orthopaedic Associates, New Brunswick, New Jersey, USA;
3Brandywine Institute of Orthopaedics, Pottstown, Pennsylvania, USA;
4Medical University of Lodz, Poland
If noted, the author indicates something of value received. The codes are identified as a-research or institutional support; b-miscellaneous funding; c-royalties; d-stock options; e-consultant or employee; n-no conflicts disclosed, and *disclosure not available at time of printing.
• The FDA has not cleared this drug and/or medical device for the use described in this presentation (i.e., the drug or medical device is being discussed for an “off label” use). ◆FDA information not available at time of printing.